Health Services · Medical/Nursing Services · NSE: AGARWALEYE · data 2026-10-09
Dr. Agarwal's Health Care Ltd.
Health check: Average (4.7/10 on quality, valuation vs sector, growth and momentum).
Open full analysis — chart, results, balance sheet, red flags →Key figures
Price
₹477.75
Market cap
₹14,907 cr
P/E
102.7
P/B
—
ROE
6.8%
ROCE
9.1%
Debt / equity
0.53
Dividend yield
0.00%
1-year return
-3.9%
52-week high
₹568
52-week low
₹401
Operating margin
14.5%
Growth
| Revenue (last 12 months) | ₹2,207 cr |
| Net profit (last 12 months) | ₹148 cr |
| Sales growth, 3 years (yearly) | 26.9% |
| Profit growth, 3 years (yearly) | 12.3% |
Chart patterns
- Descending triangle — breakdown (key level ₹484.15)
Similar companies
Dr. Lal PathLabs Limited (LALPATHLAB) · Vijaya Diagnostic Centre Ltd. (VIJAYA) · Metropolis Healthcare Ltd. (METROPOLIS) · Thyrocare Technologies Ltd (THYROCARE) · Nephrocare Health Services Limited (NEPHROPLUS)
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open AGARWALEYE in NSE Scanner →